SCHEMBL12722007

SCHEMBL12722007

Cc1cc(-c2nnc(-c3ccccc3)o2)c(C)cc1-c1ccc(-c2nc3ccccc3nc2-c2ccc(-c3cc(C)c(-c4nnc(-c5ccccc5)o4)cc3C)cc2)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 10/20 0.55
NPC1 O15118 9/20 0.55
SMN1; SMN2 Q16637 8/20 0.55
HPGD P15428 7/20 0.55
ALDH1A1 P00352 6/20 0.55
TSHR P16473 5/20 0.55
NFKB1 P19838 2/20 0.51
NFKB2 Q00653 2/20 0.51
RELA Q04206 2/20 0.51
TDP1 Q9NUW8 2/20 0.51
POLB P06746 1/20 0.51
PTGS2 P35354 2/20 0.47
HSD17B10 Q99714 2/20 0.47
KDM4E B2RXH2 5/20 0.46
GAA P10253 2/20 0.46
L3MBTL1 Q9Y468 3/20 0.45
PDE10A Q9Y233 1/20 0.45
MAOB P27338 1/20 0.45
LMNA P02545 3/20 0.44
CYP1A2 P05177 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12721718 1.00 RAB9A (0.55) RAB9ANPC1SMN1; SMN2HPGDALDH1A1
SCHEMBL12721754 0.94 NPC1 (0.51) RAB9ANPC1SMN1; SMN2HPGDALDH1A1
SCHEMBL12722026 0.92 RAB9A (0.54) RAB9ANPC1SMN1; SMN2HPGDALDH1A1
SCHEMBL13589290 0.87 RAB9A (0.67) RAB9ANPC1SMN1; SMN2HPGDALDH1A1
SCHEMBL12722000 0.85 RAB9A (0.54) RAB9ANPC1SMN1; SMN2HPGDALDH1A1
SCHEMBL12721727 0.85 RAB9A (0.54) RAB9ANPC1SMN1; SMN2HPGDALDH1A1
SCHEMBL16437743 0.85 RAB9A (0.73) RAB9ANPC1SMN1; SMN2HPGDALDH1A1
SCHEMBL10315381 0.84 RAB9A (0.48) RAB9ANPC1SMN1; SMN2HPGDALDH1A1
SCHEMBL10315151 0.84 RAB9A (0.48) RAB9ANPC1SMN1; SMN2HPGDALDH1A1
SCHEMBL12722062 0.84 RAB9A (0.56) RAB9ANPC1SMN1; SMN2HPGDALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7927720-B2 Quinoxaline derivative and light-emitting element, light-emitting device, and electronic device using quinoxaline derivative SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2011-04-19 US disclosed
US-20090140641-A1 Quinoxaline Derivative and Light-Emitting Element, Light-Emitting Device, and Electronic Device Using Quinoxaline Derivative SEMICONDUCTOR ENERGY LABORATORY CO., LTD. 2009-06-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090140641-A1 Quinoxaline Derivative and Light-Emitting Element, Light-Emitting Device, and Electronic Device Using Quinoxaline Derivative PDXK, PPOX, NQO1 RAB9A 2280/4885NPC1 4849/4885SMN1; SMN2 4028/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.